Riociguat


( Last Updated : September 30, 2013)
Generic Name:
Riociguat
Project Status:
Complete
Therapeutic Area:
Chronic thromboembolic pulmonary hypertension
Manufacturer:
Bayer Inc.
Call for patient/clinician input open:
Brand Name:
Adempas
Project Line:
Reimbursement Review
Project Number:
SR0353-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Pulmonary hypertension, chronic thromboembolic
Recommendation Type:
List with criteria/condition
Final Recommendation: